Stay updated on Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial page.

Latest updates to the Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial page
- Check3 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference6%
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.3%
- Check39 days agoChange DetectedThe page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
- Check54 days agoChange DetectedThe web page has been updated to a new version, v2.14.4, replacing the previous version v2.14.3. Additionally, a date of April 3, 2025, has been added.SummaryDifference0.6%
- Check68 days agoChange DetectedThe date for an event has been updated from November 19, 2024, to March 24, 2025.SummaryDifference1.0%
- Check97 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
Stay in the know with updates to Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial page.